Latest News about Expert Ideas
Recent news which mentions Expert Ideas
Cannabis Can Be A 'Great Tool In Dealing With Adversity,' Says Former NFL Star Ricky Williams
October 18, 2024
From Benzinga
EXCLUSIVE: Jim Belushi Speaks Out On Marijuana Reform, Says 'Cannabis Doesn't Kill Anybody, Alcohol Does'
October 18, 2024
Tickers
CCC
From Benzinga
Bitcoin Is 'The Simplest Story In Finance,' Will Climb Regardless Of Election Winner, Says Anthony Pompliano
October 18, 2024
From Benzinga
From Benzinga
Wall Street's Most Accurate Analysts Give Their Take On 3 Financials Stocks Delivering High-Dividend Yields
October 18, 2024
From Benzinga
Broadcom, Marvell Set To Lead In 2025 As Sector Is 'At The Cusp Of A Semiconductor Up-Cycle,' Says Analyst
October 18, 2024
From Benzinga
First Solar, NextEra, Enphase: What Post-Election Scenarios Could Mean For Renewable Powerhouses
October 18, 2024
From Benzinga
Top 2 Tech And Telecom Stocks That May Crash In Q4
October 18, 2024
From Benzinga
Top 2 Energy Stocks Which Could Blast Off This Month
October 18, 2024
From Benzinga
Bitcoin Takes Aim At All-Time Highs: What Does It Mean For Altcoins?
October 18, 2024
From Benzinga
Procter & Gamble Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
October 18, 2024
From Benzinga
SLB Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
October 18, 2024
From Benzinga
Google Deal For Default Search On Apple iPhones 'Very Likely' To Be Banned, Jefferies Says
October 17, 2024
From Benzinga
Bitcoin, Ethereum, Dogecoin Consolidate With A Down Day, But: 'Second Leg Of The Bull Cycle Is Underway,' Says Trader
October 17, 2024
From Benzinga
Gold Could Reach $3,000 By 2025, Bank Of America Analyst Says: 'Ultimate Perceived Safe Haven'
October 17, 2024
From Benzinga
Abbott Labs Path to Double-Digit Earnings Growth In 2025? This Analyst Is Optimistic
October 17, 2024
From Benzinga
From Benzinga
Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
October 17, 2024
From Benzinga
First Watch Poised To Reach Its Goal Of Over 2,200 Domestic Locations Despite Tough Macro Conditions, Says Analyst
October 17, 2024
From Benzinga
Why Is Elevance Health Stock Trading Lower On Thursday?
October 17, 2024
From Benzinga
Morgan Stanley Analysts Optimistic After Q3: Fed Rate Declines 'Should Drive Robust Growth' In Asset Management
October 17, 2024
Tickers
MS
From Benzinga
Ulta Beauty Faces 'Transitional' FY25, May Fall Short Of Long-Term Targets: Analyst
October 17, 2024
From Benzinga
Alcoa Analyst Boosts Price Target: Growth Strategy Hinges On Kwinana Savings, San Ciprian Resolution
October 17, 2024
From Benzinga
Stanley Druckenmiller: Crypto Is Pricing In Trump As Election Favorite, But Does Bitcoin's Surge Coincide With Rising Odds?
October 17, 2024
From Benzinga
From Benzinga
Constellation Energy Stock Deserves 'Substantial Premium To The S&P 500' Says JPMorgan Analyst
October 17, 2024
From Benzinga
Strong September Retail Sales Put Fed's Next Move In Doubt: Interest Rate Cuts Are 'Not A Slam Dunk'
October 17, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.